Government Issues Recalls Affecting KZ RV
January 25, 2021
The National Highway Traffic Safety Administration (NHTSA) has issued the following recalls:
RV Manufacturing
Alliance RV Debuts Valor Line
January 19, 2021
Alliance RV revealed its Valor toy hauler line at last week’s RV SuperShow in Tampa, Florida.
NHSTA Issues Recalls Affecting Heartland RVs
January 18, 2021
The National Highway Traffic Safety Administration (NHTSA) has issued the following recalls.
Keystone RV Reveals New Arcadia Line
January 13, 2021
Thor Industries’ towable manufacturer Keystone RV debut its new fifth wheel line, dubbed the Arcadia, at the Florida RV SuperShow on Jan. 13.
EXCLUSIVE: Venture RV On New SportTrek Touring
January 13, 2021
Venture RV, a division of KZ Recreational Vehicles, released its latest SportTrek Touring floorplan, the 343VI.
Government Issues Recalls Affecting Industry
January 11, 2021
The National Highway Traffic Safety Administration) has issued the following recalls.
Keystone RV to Launch New Fifth Wheel Line
January 7, 2021
Keystone RV announced plans to launch a new fifth wheel lineup Jan. 13 at the Florida RV Super Show.
Government Issues Recalls Affecting Industry
January 4, 2021
The National Highway Traffic Safety Administration (NHTSA) has issued the following recalls:
nuCamp Barefoot to Hit U.S. Production Lines
January 4, 2021
nuCamp RV, a camper and teardrop trailer manufacturer, announced Dec. 30 an Americanized version of the U.K.-based Barefoot will hit U.S. production lines in the near future.
Winnebago’s Happe Addresses Type B Competition
December 22, 2020
Improving supply chain challenges and Type B market competition were addressed in Winnebago Industries’ fiscal 2021 first quarter review.
Winnebago’s Happe Addresses Electric RV Future
December 22, 2020
Electrified RVs are not new to Winnebago Industries, President and CEO Michael Happe said in response to a recent question regarding electrification.
Medicine Company to Deploy RV Research Labs
December 22, 2020
Eli Lilly and Co. will deploy RV units as mobile research labs in a pragmatic study of its “bamlanivimab” medicine in New Mexico-based Covid patients.